July 26, 2024

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

by

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

Please follow and like us:
Pin Share

You may also like